Novel Effect biomarkers for MEtabolic disruptorS: evidence on health Impacts to answer science and policy needS

Projektinformationen

NEMESIS

ID Finanzhilfevereinbarung: 101137405

DOI 10.3030/101137405

EK-Unterschriftsdatum 8 Dezember 2023

Startdatum 1 Januar 2024

Enddatum 31 Dezember 2028

Finanziert unter

• Health

Gesamtkosten € 7 965 638,75

EU-Beitrag € 7 881 685,25

Koordiniert durch

ITA-SUOMEN YLIOPISTO
Finland

Leistungen

Websites, patent fillings, videos etc. (3)

NEMESIS Brochure

Leaflet on information for dissemination (events)

NEMESIS website

A project dedicated public website (continuously updated)

NEMESIS Initial press release

Initial press release describing the overall goals and ambition